These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 17351394
1. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin. Koehn H, Magan N, Isaacs RJ, Stowell KM. Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394 [Abstract] [Full Text] [Related]
2. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis. Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R. J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498 [Abstract] [Full Text] [Related]
3. DNA repair after irradiation in glioma cells and normal human astrocytes. Short SC, Martindale C, Bourne S, Brand G, Woodcock M, Johnston P. Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360 [Abstract] [Full Text] [Related]
4. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression. Fan R, Kumaravel TS, Jalali F, Marrano P, Squire JA, Bristow RG. Cancer Res; 2004 Dec 01; 64(23):8526-33. PubMed ID: 15574758 [Abstract] [Full Text] [Related]
5. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair. Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, Bristow RG. Cancer Res; 2010 Nov 01; 70(21):8748-59. PubMed ID: 20940401 [Abstract] [Full Text] [Related]
6. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH. Cell Biochem Biophys; 2009 Nov 01; 55(2):95-105. PubMed ID: 19593673 [Abstract] [Full Text] [Related]
7. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells. Frankenberg-Schwager M, Becker M, Garg I, Pralle E, Wolf H, Frankenberg D. Radiat Res; 2008 Dec 01; 170(6):784-93. PubMed ID: 19138034 [Abstract] [Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Rojo F, González-Navarrete I, Bragado R, Dalmases A, Menéndez S, Cortes-Sempere M, Suárez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sánchez-Pérez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, Perona R, Rovira A, Albanell J. Clin Cancer Res; 2009 May 15; 15(10):3530-9. PubMed ID: 19417026 [Abstract] [Full Text] [Related]
9. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. de Campos-Nebel M, Larripa I, González-Cid M. Mutat Res; 2008 Nov 10; 646(1-2):8-16. PubMed ID: 18812179 [Abstract] [Full Text] [Related]
10. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Meng AX, Jalali F, Cuddihy A, Chan N, Bindra RS, Glazer PM, Bristow RG. Radiother Oncol; 2005 Aug 10; 76(2):168-76. PubMed ID: 16026872 [Abstract] [Full Text] [Related]
11. Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks. Henson SE, Tsai SC, Malone CS, Soghomonian SV, Ouyang Y, Wall R, Marahrens Y, Teitell MA. Mutat Res; 2006 Oct 10; 601(1-2):113-24. PubMed ID: 16920159 [Abstract] [Full Text] [Related]
12. p53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line. Orre LM, Stenerlöw B, Dhar S, Larsson R, Lewensohn R, Lehtiö J. Biochem Biophys Res Commun; 2006 Apr 21; 342(4):1211-7. PubMed ID: 16516153 [Abstract] [Full Text] [Related]
13. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells. Vernole P, Muzi A, Volpi A, Dorio AS, Terrinoni A, Shah GM, Graziani G. Mutat Res; 2009 May 12; 664(1-2):39-47. PubMed ID: 19428379 [Abstract] [Full Text] [Related]
14. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven. Wiltshire T, Senft J, Wang Y, Konat GW, Wenger SL, Reed E, Wang W. Mol Pharmacol; 2007 Apr 12; 71(4):1051-60. PubMed ID: 17229870 [Abstract] [Full Text] [Related]
15. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Connell PP, Jayathilaka K, Haraf DJ, Weichselbaum RR, Vokes EE, Lingen MW. Int J Oncol; 2006 May 12; 28(5):1113-9. PubMed ID: 16596227 [Abstract] [Full Text] [Related]
16. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines. Slebos RJ, Taylor JA. Biochem Biophys Res Commun; 2001 Feb 16; 281(1):212-9. PubMed ID: 11178982 [Abstract] [Full Text] [Related]
17. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R. Oncogene; 2005 Nov 17; 24(51):7542-51. PubMed ID: 16044152 [Abstract] [Full Text] [Related]
18. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Maacke H, Jost K, Opitz S, Miska S, Yuan Y, Hasselbach L, Lüttges J, Kalthoff H, Stürzbecher HW. Oncogene; 2000 May 25; 19(23):2791-5. PubMed ID: 10851081 [Abstract] [Full Text] [Related]
19. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Schonn I, Hennesen J, Dartsch DC. Apoptosis; 2010 Feb 25; 15(2):162-72. PubMed ID: 20041303 [Abstract] [Full Text] [Related]
20. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E. Cancer Lett; 2007 Dec 18; 258(2):181-8. PubMed ID: 17920763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]